Involvement ofthe lungs in rheumatoid arthritis (RA) has been found in varying degrees depending on the method of investigation. Lung changes in RA have been reported by several authors. The prevalence depends on the method of investigation, namely, whether autopsy (Aronoff, Bywaters, and Fearnley, 1955; Talbott and Calkins, 1964 ), x-ray (Horler and Thompson, 1959; Georg, 1961; Sievers, Hurri, and Perttala, 1964; Brannan and others, 1964; Patterson, Harville, and Pierce, 1965; Pierce, 1968; Walker and Wright, 1969; Vignon, 1972; Hofner, LobenweinWeinegg, and Thumb, 1974) , or lung function (Newcomer and others, 1964; Huang and Lyons, 1966; Loddenkemper, Bach, and Carton, 1970; Popper, Bogdonoff, and Hughes, 1972; Frank and others, 1973; Laitinen, Salorinne, and Poppius, 1973; Morere, Stain, and Nouvet, 1973; Davidson, Brooks, and Bacon, 1974; Borngen, 1975) was applied.
Rheumatoid factors have also been shown frequently in idiopathic interstitial fibrosis of the lung (Tomasi, Fudenberg, and Fiuby, 1962; TurnerWarwick and Doniach, 1965; Ward and Stalker, 1965) , in which case morphological changes often appear to be very similar to those seen in rheumatoid lung disease. Hence, several authors have looked for a dependency of lung function changes on seropositive arthritis and found a higher frequency of overall lung function disturbance in seropositive RA (Frank and others, 1973; Morere and others, 1973) . The question arose whether these changes were due to a general deterioration of the arthritic patient, or to the influence of the immunological process itself on certain well-defined lung function parameters.
Patients Sixty-two patients (55 women, 7 men) with classical or definite RA were submitted to lung function analysis. Classification was made according to Steinbrocker, Traeger, and Batterman (1949 Seropositive rheumatoid arthritis associated with decreased diffusion capacity ofthe lung 259 Baldwin, Cournand, and Richards (1948) , FEV1 was expressed in "VC, FRC and RV in %TLC, specific compliance was considered normal > 0-055; lower limit of normal for specific DLCO was 4-5 units/l FRC.
Bronchial obstruction was assessed by airway resistance > 3 0 and/or FEV1 < 60 %VC, as well as by proportional increase of the area of the compliance loop during maximal ventilation.
Results
Mean values (with standard deviation) of lung function parameters of the 62 RA patients are given in Table II ; these values are shown for seropositive and seronegative patients separately, indicating the percentage of patients with abnormal findings. Individual lung function parameters were compared with clinical data and a statistically significant correlation was found between rheumatoid factor and specific DLCO only. There were no statistically significant correlations in other parameters. However, a pathological specific compliance was noticed more frequently in patients of Steinbrocker stages 3 and 4 than in those of 1 and 2. A linear relationship, however, did not exist between a decrease of specific compliance and stage of the disease. The group of patients with pathological specific DLCO showed some increase with Steinbrocker stages, but this was not significant.
The results indicate some correlation between DLCO and the presence of rheumatoid factor and its titre, respectively. Decreased DLCO occurred more frequently in seropositive patients (P < 0-05), the mean values differing significantly between the two groups (P < 0025). The higher the RF titre the larger the percentage of patients with impaired DLCO (P < 0O01 (Fassbender, 1975) in RA: a nonspecific reaction of the endothelium seen in a variety of inflammatory diseases, being followed by exudation in the surrounding tissue (pneumonitis). This alteration is reversible in the early stage, but may lead to an irreversible fibrosis. Only in seropositive patients might an additional process consisting of necrosis of the arterial wall occur due to autoantibodies or immune-complex deposits. Secondarily, fibroblasts invade the necroses and cellular proliferation of the endothelium occurs. However, these changes have been reported in the vessels of the systemic circulation only; no author refers explicitly to analogous changes in the lesser circulation. A different mechanism has been discussed by Nagaya, Buckley, and Sieker (1969) who stressed the fact of immune-complex deposits in the alveolar wall of patients with progressive idiopathic interstitial fibrosis. The decrease of lung compliance found frequently in RA is probably due to inflammatory changes of interstitial tissue, which can develop into interstitial fibrosis. Because interstitial, vascular, and alveolar changes can develop independently ofeach other and, therefore, may not occur to a similar extent in a given patient, compliance and DLCO are not necessarily decreased in the same way.
Restriction of lung volumes can be due to pleurisy, increased thoracic rigidity (Huang and Lyons, 1966) , and to rheumatoid myopathy. A slight to moderate inspiratory shift of midbreathing level (FRC in % TLC) and increase in residual volume (in % TLC) can be due either to the decrease in inspiratory reserve volume, or simply to age-dependent changes of the lung. However, the distribution of these alterations is nearly equal among seropositive and seronegative groups. Bronchial obstruction (as indicated by raised airway resistance and decreased FEV1) was found in 17-7 %. Smoking habits (9 patients, 14-5 %) should not be neglected entirely when changes in DLCO are being reported. However, the distribution of these patients was equal in the respective groups. Lung function changes in RA are certainly of multifactorial origin. Our 
